We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
-14.03%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$22.9B
AUM Growth
-$4.32B
Cap. Flow
-$424M
Cap. Flow %
-1.85%
Top 10 Hldgs %
13.89%
Holding
1,428
New
104
Increased
438
Reduced
568
Closed
134

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$499M
2
BMY icon
Bristol-Myers Squibb
BMY
+$59.2M
3
HUM icon
Humana
HUM
+$54.1M
4
EMR icon
Emerson Electric
EMR
+$47.7M
5
TGT icon
Target
TGT
+$45.5M

Top Sells

Rank Stock Value
1
HOLX
Hologic
HOLX
+$68.5M
2
SYK icon
Stryker
SYK
+$50.3M
3
JNJ icon
Johnson & Johnson
JNJ
+$46.2M
4
NVDA icon
NVIDIA
NVDA
+$44.1M
5
SWK icon
Stanley Black & Decker
SWK
+$40.5M

Sector Composition

Rank Sector Weight
1 Technology 21.77%
2 Healthcare 16.07%
3 Financials 11.39%
4 Consumer Discretionary 9.78%
5 Industrials 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LULU icon
301
lululemon athletica
LULU
$10.9B
$17M 0.07%
140,135
+62,285
+80% +$8.35M
XRX icon
302
Xerox
XRX
$454M
$17M 0.07%
861,726
-9,450
-1% -$243K
OMC icon
303
Omnicom Group
OMC
$21.9B
$16.7M 0.07%
227,651
-9,300
-4% -$690K
HUN icon
304
Huntsman Corp
HUN
$1.62B
$16.4M 0.07%
852,800
-19,700
-2% -$423K
KEYS icon
305
Keysight
KEYS
$53.3B
$16.3M 0.07%
263,229
+213,700
+431% +$12.9M
CAT icon
306
Caterpillar
CAT
$360B
$16.3M 0.07%
128,229
+2,703
+2% +$352K
GIB icon
307
CGI
GIB
$14.9B
$16.3M 0.07%
265,872
-119,100
-31% -$7.35M
BAX icon
308
Baxter International
BAX
$12.3B
$16.3M 0.07%
247,054
-150,801
-38% -$10.1M
GAP
309
The Gap Inc
GAP
$7.18B
$16.3M 0.07%
630,962
-9,600
-1% -$257K
PAGS icon
310
PagSeguro Digital
PAGS
$2.65B
$16.2M 0.07%
865,913
-44,200
-5% -$1.08M
CNK icon
311
Cinemark Holdings
CNK
$3.93B
$16.2M 0.07%
452,000
-121,700
-21% -$4.81M
TT icon
312
Trane Technologies
TT
$93B
$16M 0.07%
175,241
+88,975
+103% +$8.75M
IRM icon
313
Iron Mountain
IRM
$33.4B
$15.9M 0.07%
490,164
+125,100
+34% +$4.1M
RHT
314
DELISTED
Red Hat Inc
RHT
$15.9M 0.07%
90,250
-19,600
-18% -$3.11M
PGR icon
315
Progressive
PGR
$129B
$15.7M 0.07%
260,001
-26,144
-9% -$1.74M
GLOB icon
316
Globant
GLOB
$1.73B
$15.6M 0.07%
277,673
+15,961
+6% +$856K
DRE
317
DELISTED
Duke Realty Corp.
DRE
$15.6M 0.07%
603,361
+176,296
+41% +$4.89M
AVGO icon
318
Broadcom
AVGO
$1.62T
$15.4M 0.07%
607,040
+280
+0% +$6.61K
NFX
319
DELISTED
Newfield Exploration
NFX
$15.3M 0.07%
1,044,294
-84,742
-8% -$1.71M
PAYX icon
320
Paychex
PAYX
$42.1B
$15.2M 0.07%
232,551
-1,700
-0.7% -$115K
AVT icon
321
Avnet
AVT
$7.6B
$15M 0.07%
414,533
+757
+0.2% +$30.9K
ALGN icon
322
Align Technology
ALGN
$10.4B
$15M 0.07%
71,416
-31,534
-31% -$7.97M
HUBS icon
323
HubSpot
HUBS
$12.1B
$14.9M 0.07%
118,708
+21,299
+22% +$2.79M
STOR
324
DELISTED
STORE Capital Corporation
STOR
$14.9M 0.06%
525,174
+65,577
+14% +$1.91M
NTRS icon
325
Northern Trust
NTRS
$32.7B
$14.8M 0.06%
177,608
+14,300
+9% +$1.34M

Similar funds

Axa's Q4 2018 Portfolio in Review

As of Q4 2018, Axa held 1,428 positions worth $22.9B, down 16% from $27.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Axa's Q4 2018 filing shows 104 new, 438 increased, 568 reduced and 134 closed positions. Its largest new stake was Linde: 3,157,617 shares worth $493M. The largest sale was Hologic, an estimated $68.5M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Axa's largest Q4 2018 buy was Linde: 3,157,617 shares worth $493M.
  • Axa added most to Bristol-Myers Squibb in Q4 2018, an estimated $59.2M increase.
  • Axa's biggest Q4 2018 reduction was Hologic, cutting an estimated $68.5M.
  • Axa fully exited Praxair Inc in Q4 2018, selling an estimated $25.6M.
  • Axa's ten largest holdings make up 14% of its $22.9B portfolio in Q4 2018.
  • Axa opened 104 new positions and closed 134 in Q4 2018.
  • Axa's portfolio value fell 16% quarter-over-quarter to $22.9B.

Based on Axa's 13F filing for Q4 2018, filed 13 Feb 2019.